entertainment -WSS

entertainment

author：explore 2025-09-30 17:59:38 - browse：39

Mouse embryo in bottle. -- coverage from STAT — A mouse embryo model created entirely from stem cells. Scientists have since used similar systems to build models of human embryos. Jacob Hanna —Weizmann Institute

Earlier this month, a British journalist broke the news that researchers had taken a major step toward growing stem cells into structures that resemble human embryos.

Details about the experiments, and any sort of outside analysis of their quality or significance, were scarce, since the academic paper summarizing the work was still under peer review. But as the news spread around the globe, other scientists who had more quietly been working in the same area quickly posted preprints of their own progress.

Almost overnight, it seemed, the world was awash in different ways to coax stem cells into something that looked like the earliest days of a human life. The pushback was immediate, prompting accusations of overblown claims as well as outcry about ethical considerations and legal guardrails lagging behind the pace of scientific progress. Meanwhile, former Trump adviser Steve Bannon’s podcast, which studies have found to be a top spreader of misinformation, denounced synthetic babies as “the next abomination.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Burning questions for the 2024 JPM Healthcare Conference

WSS

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Chronically ill young patients struggle to find fertility info

ActiGraph execs on goal of drug approvals with digital endpoints

The FDA must approve intranasal treatments for anaphylaxis

The FDA must approve intranasal treatments for anaphylaxis

GSK Flovent asthma inhalers replaced by authorized generics

leisure time

entertainment

explore

Wildfire smoke exposes gaps in outdoor worker protections

Trump cancels press conference intended to dispute Georgia election interference charges

What does generative AI mean for health care? We asked experts

ActiGraph execs on goal of drug approvals with digital endpoints

Moonlake's readout produced a cash windfall. Risks remain

Hilary expected to bring catastrophic, life

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Eye stem cell transplant could help restore vision in injured people

Bright Health sells Medicare Advantage business to Molina

UCB departs biotech trade group BIO

focus

New details revealed about Purdue's marketing of OxyContin

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Ahead of JPM, here's who's profiting most in health care

Feng Zhang CRISPR delivery startup lays off quarter of staff

Antibiotic resistance and the global rise in human conflict

Listen: Racing for gene therapy & a pioneering approval

explore

focus

hotspot

focus